Eikon Therapeutics (EIKN) vs Scribe Therapeutics (SCTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Eikon Therapeutics is the larger company by market cap ($406.2 million vs $364.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EIKN | SCTX |
|---|---|---|
| Share price | $7.50 | $19.23 |
| Market cap | $406.24M | $364.06M |
| 1-day change | -0.53% | +9.45% |
| EPS (TTM) | $-8.51 | $-3.84 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.40 | $39.60 |
| 52-week low | $7.02 | $13.50 |
| Distance from 52-week high | -56.90% | -51.44% |
| Analyst consensus | none | none |
| Avg. price target upside | +228.00% | +196.41% |
| Average volume | 492.68K | 357.50K |
| Shares outstanding | 54.17M | 18.93M |
| Employees | 384 | 82 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Eikon Therapeutics
EIKN stock →Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 384 employees
About Scribe Therapeutics
SCTX stock →Scribe Therapeutics Inc. operates as a clinical-stage biotechnology company, focuses on research and developing genetic medicines using CRISPR-based tools to address the root cause of diseases, with a primary focus on cardiometabolic conditions in the United States.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 82 employees
EIKN vs SCTX FAQ
Which is bigger, Eikon Therapeutics or Scribe Therapeutics?
Eikon Therapeutics (EIKN) is larger, with a market capitalization of $406.24M compared with $364.06M for Scribe Therapeutics (SCTX).
Are Eikon Therapeutics and Scribe Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.